Progenics Pharmaceuticals Announces First Patient Dosed in Phase 2/3 Clinical Trial of PSMA-Targeted PET/CT Imaging Agent PyL™ Life Science Investing
Kitov Successfully Completes All KIT-302 Testing Required for New Drug Application to US FDA Pharmaceutical Investing
Novartis Announces Zykadia® First-Line Study Results Showing 16.6 Month Progression-Free Survival in Patients with ALK+ Advanced NSCLC Life Science Investing
Reata Pharmaceuticals Announces Filing of Registration Statement for Proposed Public Offering Biotech Investing
Inovio MERS Vaccine Development to be Expanded with Funding from International Vaccine Institute Biotech Investing
AzurRx BioPharma Announces Agreement in Principle with TransChem for MTAN Inhibition Technology Biotech Investing
Cerecor Announces Top-Line Results from CERC-501 Phase 2 Study for Nicotine Withdrawal Biotech Investing
EyeGate Reports Positive Data from Third Stage of Phase 1b/2a Clinical Trial of EGP-437 in Cataract Surgery Patients Pharmaceutical Investing
Aegerion Pharmaceuticals, a Subsidiary of Novelion Therapeutics, Enters into Agreement in Principle to Settle Class Action Shareholder Lawsuit Biotech Investing
Biothera Pharmaceuticals and Merck Expand Research Collaboration to Include Phase 2 Clinical Trial in Head and Neck Cancer Biotech Investing
Novo Nordisk Files for Regulatory Approval of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes Life Science Investing
